- ￥463 - 2465
- Solarbio
- 北京
- IA4840
- 2026年07月30日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 保质期：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 英文名：
AX-024 Hydrochloride
- 库存：
现询
- 供应商：
北京索莱宝科技有限公司
- CAS号：
1704801-24-0
- 规格：
25mg/10mg/1mg/5mg
| 规格： | 25mg | 产品价格： | ￥2465.0 |
|---|---|---|---|
| 规格： | 10mg | 产品价格： | ￥1697.0 |
| 规格： | 1mg | 产品价格： | ￥463.0 |
| 规格： | 5mg | 产品价格： | ￥1090.0 |
| 基本信息 | |
| CAS | No.1704801-24-0 |
| 中文名称 | AX-024盐酸盐 |
| 英文名称 | AX-024 Hydrochloride |
| 分子式 | C21H23ClFNO2 |
| 分子量 | 375.86 |
| 溶解性 | Soluble in Water/DMSO ≥1mg/mL |
| 纯度 | ≥98% |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year |
| MDL | MFCD31628548 |
| SMILES | COC1=CC=C(OC2)C(C(C3=CC=C(F)C=C3)=C2CN4CCCC4)=C1.[H]Cl |
| InChIKey | DGBCIMPGYRVTPD-UHFFFAOYSA-N |
| InChI | InChI=1S/C21H22FNO2.ClH/c1-24-18-8-9-20-19(12-18)21(15-4-6-17(22)7-5-15)16(14-25-20)13-23-10-2-3-11-23;/h4-9,12H,2-3,10-11,13-14H2,1H3;1H |
| PubChem CID | 129909862 |
| 靶点 | TCR;IFNAR；Interleukin Related |
| 通路 | Immunology & Inflammation |
| 背景说明 | 是一种TCR-Nck 相互作用抑制剂，可选择性地抑制 TCR 触发的 T 细胞活化；还可以有效抑制白细胞介素-6 (IL-6)，肿瘤坏死因子-α (TNFα)，干扰素-γ (IFN-γ)，IL-10 和 IL-17A 的产生。 |
| 生物活性 | AX-024 hydrochloride is an orally available， first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024 hydrochloride modulates cell signaling by targeting SH3 domains. AX-024 hydrochloride has low-acute toxicity and high potency and selectivity， and strongly inhibit the production of IL-6， TNF-α， IFN-γ， IL-10 and IL-17A.[1] |
| In Vitro | AX-024 hydrochloride is >10，000-fold more potent than the AX-000 hit in terms of inhibition of TCR-triggered T cell proliferation. The IC50 of AX-024 hydrochloride in this assay is 1 nM， although it shows inhibitory effects at a concentration of 1 pM or less. AX-024 hydrochloride is also a much more potent inhibitor of cytokine release by human peripheral blood mononuclear cells stimulated with anti-CD3 than AX-000， strongly hindering interleukin-6 (IL-6)， tumor necrosis factor-α (TNFα)， interferon-γ (IFN-γ)， IL-10， and IL-17A production at a concentration of 10 nM. In CD8+ T cells of OT1 TCR transgenic (OT1Tg) mice bearing wild-type (WT) AX-024 hydrochloride strongly inhibits T cell proliferation at a concentration of 0.1 nM when OT1Tg T cells are WT for the PRS mutation. Coimmunoprecipitation experiments in these cells show that Nck recruitment to the TCR is induced upon stimulation in the absence of drug but is inhibited in the presence of AX-024 hydrochloride in a dose-dependent manner at concentrations starting from 1 nM[1]. |
| 细胞实验 | The AX-024 hydrochloride-treated group presents less scales and reduces skin thickening compare to the vehicle group. AX-024 hydrochloride significantly reduces thickening of both skin layers， but more effectively of the dermis， which rather resembles that of mice treated with a control cream lacking imiquimod (IMQ). AX-024 hydrochloride significantly diminishes the number of airway inflammatory cells in both assays. Mice receiving AX-024 hydrochloride rapidly recovers from neurological impairment and weight loss， becoming symptom-free by day 30， unlike mice that receives the vehicle， in which ataxia and loss of the righting reflex persist[1]. |
| 细胞实验 | Spleen B cells from C57BL/6 mice are labeled with Cell Trace Violet and incubated for 72 hours with either anti-IgM (10 mg/mL) or anti-CD40 (5 mg/mL)， supplemented with IL-4 (5 ng/mL) or LPS (2.5 mg/mL) in the presence of different concentrations of AX-024 hydrochloride. Proliferation is calculated according to the total number of cell divisions[1]. |
| 动物实验 | Eight-week-old CD-1 mice are injected intraperitoneally with different amounts of the AX-024 hydrochloride dissolved in 0.5 mL of saline. All animals are observed clinically for the appearance of macroscopically visible adverse reactions twice daily over 14 days， as well as immediately after AX-024 hydrochloride administration. A necropsy is carried out on each animal on day 14， and the abdominal， thoracic， and cranial cavities are examined in situ， together with their associated organs[1]. |
| 数据来源文献 | [1]. Borroto A， et al. First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases. Sci Transl Med. 2016 Dec 21;8(370):370ra184. |
| 单位 | 瓶 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验花香蝶自来 | Solarbio小分子化合物“优秀员工展”第二十六期
你负责才华横溢，我负责万里挑一~ Solarbio作为一家小分子化合物供应商，其产品的安全性和有效性已经被大量文献证实，仅2025年SCI发表文献中，使用索莱宝产品的文献30000+篇，在Nature、Cell等刊物上的文章也层出不穷。同时，我们提供详尽的化学信息和生物学信息，并提供说明书、MSDS、质量报告等文件，旨在打造令客户满意的放心平台。 Solarbio小分子化合物系列产品已推出了数年，期间不少产品被用户频繁的订购，并发表了不错的文章，也常有用户循着文献的痕迹找到Solarbio
折叠所组成。 两条α螺旋位于抗原结合部位上部形成两个侧面,8条β折叠位于下部形成底面。所构成的深槽大约长2.5nm，宽1.0nm,深1.1nm,可结合8～20个氨基酸残基,其大小和形状适合于已加工处理的抗原片段。MHC Ⅰ类抗原分子的多态性主要位于形成两侧面的α螺旋结构上,与Ⅰ类抗原递呈抗原的功能相关，形成深槽内部氨基酸的侧链主要通过盐键、氢键与抗原多肽结合；位于深槽外部和表面氨基酸是TCR识别的部位， 上述发现是近年来基础免疫学中分子免疫学领域中最杰出的成就之一，为TCR识别MHC与加工
要求高，费用高等缺点很难广泛应用。 γ 干扰素释放实验（IGRAs），其原理为：结核杆菌感染者体内存在特异性效应 T 淋巴细胞，当其再次受结核杆菌特异性抗原刺激时会分泌大量 IFN-γ, 通过直接检测 IFN-γ（QFT）或检测分泌 IFN-γ 的效应 T 淋巴细胞（T-SPOT.TB）来判断是否存在结核分支杆菌的感染。T-SPOT.TB 作为第二代免疫学技术的代表灵敏度和特异性达到 90% 左右，QFT 作为第三代免疫学技术的代表，其诊断灵敏度和特异度均超过 95%。这远高于其他检测
技术资料暂无技术资料 索取技术资料
